12:00 AM
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

MiStent: Completed Phase II enrollment

Micell completed enrollment of 183 patients with stable or unstable angina pectoris or ischemia in the single-blind, international Phase II DESSOLVE II trial comparing MiStent sirolimus-eluting coronary stent vs. Endeavor zotarolimus-eluting stent. Medtronic Inc. (NYSE:MDT, Minneapolis,...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >